Introducing the new AltIndexLearn more
Verrica Pharmaceuticals

Verrica Pharmaceuticals (VRCA) Earnings Prediction

Updated August 11, 2026 · AltIndex alt-data view going into the print

AltIndex AI Score on Verrica Pharmaceuticals is 47 — signals are mixed heading into the print. Underlying trend: 3 of 5 tracked signals trending up over the last 3 months.

Next report
Thursday, November 12, 2026
EPS Estimate
$-0.44
AltIndex AI Score
47
AI Prediction
Mixed signals

VRCA stock price — last 3 months

Verrica Pharmaceuticals (VRCA) is trading at $5.22, down 29.2% over the last 3 months (from $7.37 three months ago).

What the alt-data signals say about Verrica Pharmaceuticals right now

Trends across the last 3 months — the run-up to Verrica Pharmaceuticals’s next earnings print.

Signal Current 3-month change
Job postings 9 ↑ +125.0%
LinkedIn headcount 86 ↑ +6.2%
Web traffic 4,479 ↑ +16.1%
Employee business outlook 41% Negative → flat
X followers 337 → -0.3%

Full daily-resolution trend charts on every signal are on the VRCA ticker page.

Get alerted when VRCA signals inflect

AltIndex stock alerts fire when alt-data on VRCA breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.

Sign up to AltIndex →

Verrica Pharmaceuticals earnings: frequently asked questions

When does Verrica Pharmaceuticals report earnings next?
Verrica Pharmaceuticals (VRCA) is scheduled to report next earnings on Thursday, November 12, 2026. The exact pre-market or post-market time is set by the company a few days ahead; see the official investor-relations page for confirmation.
What does the AltIndex AI Score say about Verrica Pharmaceuticals going into earnings?
Current AI Score on Verrica Pharmaceuticals: 47 — Mixed signals. The AI Score combines 10,000+ alternative-data and financial signals into one 0–100 number; higher = signals lean bullish, lower = signals lean bearish. Full per-signal breakdown is on the VRCA ticker page.
What is the EPS estimate for Verrica Pharmaceuticals?
Analyst consensus EPS estimate for Verrica Pharmaceuticals’s next quarter: $-0.44. We refresh this from analyst-estimate data daily.
How accurate are AltIndex’s earnings predictions for Verrica Pharmaceuticals?
AltIndex doesn’t predict the exact EPS number — the alt-data signals don’t see the financials. What the signals can do is tell you whether the underlying business momentum (web traffic, hiring, social audience, sentiment) supports the analyst consensus or contradicts it. AltIndex publishes the full pick history at altindex.com/results — including the misses — so you can verify how the signal-driven calls have performed.
Where can I see the full signal breakdown on Verrica Pharmaceuticals?
Visit https://altindex.com/ticker/vrca for the complete per-signal view: AI Score history, web traffic trend chart, 8-platform social audience tracking, hiring activity, news mention volume, sentiment scoring, insider trades and Congressional disclosures.
How can I get alerted before Verrica Pharmaceuticals reports earnings?
AltIndex stock alerts fire when alt-data signals on a stock break out of their historical range — often days or weeks before the earnings number confirms it. Add VRCA to your watchlist and you’ll get notified when its signals shift. See altindex.com/stock-alerts for the full alert categories.

See every alt-data signal on VRCA

Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Verrica Pharmaceuticals — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.

Sign up to AltIndex → Log in